CONMED | CNMD - Ebitda

Stock Price
38.43
Daily Change
-0.78 -1.99%
Monthly
-8.24%
Yearly
-47.27%
Q1 Forecast
37.21

CONMED reported $80.36M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
3M USD 1.68B 227M Sep/2025
Abbott USD 3.09B 44M Sep/2025
AtriCure USD 17.8M 2.45M Sep/2025
Avanos Medical USD -63.9M 85.5M Jun/2025
Baxter International USD 462M 137M Jun/2025
Becton, Dickinson and Co. USD 2.15B 674M Sep/2025
Boston Scientific USD 1.37B 9M Jun/2025
CONMED USD 80.36M 49.87M Dec/2025
Cooper Companies USD 336.6M 14.8M Sep/2025
Dexcom USD 368.4M 59.6M Sep/2025
Edwards Lifesciences USD 469M 57.7M Jun/2025
Globus Medical USD 252.6M 43.92M Sep/2025
Hologic USD 330.4M 16.6M Dec/2025
Insulet USD 160M 2.5M Sep/2025
Integra LifeSciences USD 78.45M 550.67M Sep/2025
Intuitive Surgical USD 919.7M 21M Sep/2025
J&J USD 9.52B 389M Sep/2025
Masimo USD 72M 42.6M Jun/2025
Medtronic USD 2.44B 139M Sep/2025
Merit Medical Systems USD 83.96M 10.65M Jun/2025
Olympus JPY 50.3B 17.74B Sep/2025
ResMed USD 547.48M 27.46M Dec/2025
Smith & Nephew USD 796M 139M Dec/2025
Steris USD 367.2M 13.42M Jun/2025
Stryker USD 1.67B 206M Sep/2025
Tandem Diabetes Care USD 2.77M 4.62M Sep/2025
Teleflex USD 207.62M 15.28M Jun/2025
Zimmer Biomet Holdings USD 575.7M 26.1M Jun/2025